Opportunity Information: Apply for PA 08 091

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Novel Approaches to Study Polymicrobial Diseases (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121 Oral Diseases and Disorders Research 93.173 Research Related to Deafness and Communication Disorders 93.838 Lung Diseases Research.
  • This funding opportunity was created on Dec 5, 2008 and posted on Feb 6, 2008.
  • Applicants must submit their applications by May 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments State governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized).
  • Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
Apply for PA 08 091

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Novel Approaches to Study Polymicrobial Diseases (R01) funding opportunity (PA 08 091) is an NIH research grant announcement focused on improving how scientists study infections that involve more than one microorganism at the same time. The core idea is that many real-world infections are not caused by a single pathogen acting alone; instead, disease severity and outcomes can be shaped by interactions among two or more microbes, or even among different strains of the same microbe. This program is specifically looking for innovative, mechanism-focused research that explains how these microbial combinations influence virulence and disease processes. HIV is explicitly excluded from the scope of this opportunity.

The participating NIH institutes are the National Institute of Dental and Craniofacial Research (NIDCR), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Other Communication Disorders (NIDCD). That mix of sponsors signals the types of disease contexts NIH expects to be relevant, including oral and craniofacial infections, lung-related infectious processes, and infections affecting hearing and communication-related systems. In practical terms, the FOA is positioned for investigators working in areas like oral diseases and disorders, lung diseases, and disorders related to deafness and communication, as reflected by the listed CFDA numbers (93.121, 93.838, and 93.173). Even though the scientific theme is broad, it is anchored in those institute missions, so proposed work that clearly connects polymicrobial mechanisms to these health domains would be especially aligned.

The mechanism of support is the NIH Research Project Grant (R01), meaning the announcement is intended for full, hypothesis-driven research projects with the scale and maturity typical of an R01. The FOA also notes it runs in parallel with a companion announcement of identical scientific scope (PA 08 092) that encourages applications under the R21 mechanism. The practical takeaway is that NIH provided two routes for the same scientific goals: an R01 track for more developed projects and an R21 track for earlier-stage, exploratory work, while keeping the scientific topic consistent across both announcements.

In terms of what the NIH is asking researchers to do, the emphasis is on developing and using novel approaches to understand mechanisms that affect virulence in polymicrobial infections. That can include new experimental systems, tools, models, or analytical strategies that help disentangle how microbes behave differently in a community than they do alone. The underlying goal is to move beyond simple descriptions of mixed infections and toward mechanistic insight: how microbial interactions alter pathogenic traits, how they change host responses, and how these interactions contribute to more severe, persistent, or treatment-resistant disease. The announcement is framed around “innovative approaches,” which typically implies NIH interest in new methodologies or conceptual advances rather than incremental extensions of existing single-pathogen models.

Funding and award volume are not set as fixed numbers in the summary information provided. Instead, awards are described as contingent on the availability of funds and on the receipt of enough meritorious applications. That wording is common for NIH program announcements and essentially means proposals will compete based on scientific merit and program priorities, and NIH will make awards as budgets allow.

Eligibility is broad and includes a wide range of organization types: public and private institutions of higher education, nonprofits (including those with or without 501(c)(3) status), for-profit organizations (other than small businesses and also including small businesses), state and local governments (including counties, cities/townships, special districts), independent school districts, public housing authorities/Indian housing authorities, and tribal governments and tribal organizations. The eligibility notes also make clear that foreign institutions may apply, that eligible federal agencies may apply, and that faith-based or community-based organizations may apply, expanding the applicant pool well beyond the typical university setting.

Key administrative details place the opportunity historically in the 2008-2011 window. It was posted on February 6, 2008, with an original closing date of May 7, 2011, and the same current closing date listed (May 7, 2011). It was archived on June 7, 2011. The sponsoring agency is the National Institutes of Health, and the official announcement link is provided through the NIH Grants Guide. For access issues or technical linking problems, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Overall, this FOA is best understood as an NIH effort to push the field toward better, more realistic infectious disease science by prioritizing mechanistic studies of multi-microbe infections, using the R01 mechanism for substantial research projects, and encouraging parallel exploratory work through the related R21 announcement.

FAQs: Novel Approaches to Study Polymicrobial Diseases (R01) - PA 08-091

What is the focus of the "Novel Approaches to Study Polymicrobial Diseases (R01)" funding opportunity (PA 08-091)?

This NIH program announcement supports research that improves how scientists study polymicrobial diseases, meaning infections involving more than one microorganism at the same time. The emphasis is on innovative, mechanism-focused studies that explain how combinations of microbes (including different strains of the same microbe) influence virulence, disease processes, and outcomes.

What does NIH mean by "polymicrobial" in this announcement?

In this context, "polymicrobial" refers to infections where two or more microorganisms are present together and their interactions can shape disease severity, persistence, and outcomes. The scope also includes interactions among different strains of the same microorganism when those interactions affect virulence or disease mechanisms.

What kind of science is NIH looking for under this FOA?

The announcement prioritizes innovative approaches that move beyond descriptive observations of mixed infections and instead deliver mechanistic insight. The goal is to understand how microbes behave differently in a community than in isolation, including how microbial interactions alter pathogenic traits, affect host responses, and contribute to severe, persistent, or treatment-resistant disease.

Are single-pathogen studies appropriate for this opportunity?

Based on the stated goals, the core focus is on multi-microbe (or multi-strain) interactions and how those interactions influence virulence and disease processes. Projects centered only on a single pathogen acting alone would not match the main scientific theme described.

Is HIV research allowed under PA 08-091?

No. HIV is explicitly excluded from the scope of this funding opportunity.

Which NIH institutes participate in this FOA?

The participating NIH institutes are the National Institute of Dental and Craniofacial Research (NIDCR), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Other Communication Disorders (NIDCD).

What health or disease areas are especially relevant to this FOA?

While the scientific theme is broadly about polymicrobial mechanisms, the participating institutes signal key contexts that NIH expects to be relevant, including oral and craniofacial infections, lung-related infectious processes, and infections affecting hearing and communication-related systems. Proposed work that clearly ties polymicrobial mechanisms to these domains appears especially aligned with the listed institute missions.

What grant mechanism is used for this opportunity?

The mechanism of support is the NIH Research Project Grant (R01), which is typically used for substantial, hypothesis-driven research projects at a full scale.

Is there an exploratory or smaller-project option related to this program?

Yes. The FOA notes it runs in parallel with a companion announcement of identical scientific scope (PA 08-092) that encourages applications under the R21 mechanism. The R01 route is positioned for more developed projects, while the R21 route is positioned for earlier-stage, exploratory work, with the same overall scientific topic.

What types of approaches or methods does the FOA encourage?

The FOA emphasizes "novel approaches" to understand mechanisms affecting virulence in polymicrobial infections. This can include developing and using new experimental systems, tools, models, or analytical strategies designed to disentangle how microbes interact with each other and influence the host in mixed communities.

Does the FOA specify a set amount of funding or a fixed number of awards?

No. The information provided states that awards are contingent on the availability of funds and on receiving a sufficient number of meritorious applications, meaning proposals compete based on scientific merit and program priorities within available budgets.

Who is eligible to apply?

Eligibility is broad and includes public and private institutions of higher education; nonprofits (with or without 501(c)(3) status); for-profit organizations (including small businesses and other than small businesses); state and local governments (including counties, cities/townships, special districts); independent school districts; public housing authorities/Indian housing authorities; tribal governments and tribal organizations; eligible federal agencies; and faith-based or community-based organizations.

Are foreign institutions eligible to apply?

Yes. The eligibility notes explicitly state that foreign institutions may apply.

Are small businesses eligible to apply?

Yes. The eligibility description includes for-profit organizations, including small businesses, indicating that small businesses are eligible applicants under this FOA.

Can government entities apply?

Yes. The FOA lists multiple eligible government applicant types, including state governments, local governments (counties, cities/townships), special districts, and eligible federal agencies. Tribal governments and tribal organizations are also included.

Can faith-based or community-based organizations apply?

Yes. The eligibility notes state that faith-based or community-based organizations may apply.

What are the CFDA numbers associated with this opportunity?

The opportunity is associated with CFDA numbers 93.121, 93.838, and 93.173, reflecting alignment with the participating institute missions and the health domains highlighted in the announcement summary.

When was this FOA posted and what are the key dates mentioned?

The FOA was posted on February 6, 2008. The original closing date is listed as May 7, 2011, and the current closing date is also listed as May 7, 2011. The opportunity was archived on June 7, 2011.

Where is the official announcement posted?

The official announcement is provided through the NIH Grants Guide, as indicated by the information provided.

Who should be contacted for technical issues related to accessing the announcement link?

For access issues or technical linking problems, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

What is the overall purpose of this FOA in practical terms?

In practical terms, the FOA is positioned to push infectious disease research toward more realistic, multi-microbe science by prioritizing innovative, mechanistic studies of polymicrobial infections using the R01 mechanism for substantial projects, while also pointing to a parallel R21 option for exploratory work under a companion announcement.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Novel Approaches To Study Polymicrobial Diseases (R21)

Previous opportunity: Metagenomic Analyses of the Oral Microbiome (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 091

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 091) also looked into and applied for these:

Funding Opportunity
Novel Approaches To Study Polymicrobial Diseases (R21) Apply for PA 08 092

Funding Number: PA 08 092
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
CAM Practitioner Research Education Project Grant Partnership Competitive Renewal (R25) Apply for PAR 08 095

Funding Number: PAR 08 095
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Family Planning Service Delivery Improvement Research (R01) Apply for PAR 08 999

Funding Number: PAR 08 999
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Genome Wide Association Analysis of Existing Data Sets for Arthritis and Musculoskeletal and Skin Diseases (R01) Apply for PAR 08 123

Funding Number: PAR 08 123
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mouse Models Containing Human Alleles Novel Tools to Study Brain Function (R21/R33) Apply for PAR 08 158

Funding Number: PAR 08 158
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Adverse Metabolic Side Effects of Second Generation Psychotropic Medications Leading to Obesity and Increased Diabetes Risk (R01) Apply for PAR 08 160

Funding Number: PAR 08 160
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanisms of Alcohol Induced Tissue Injury (R01) Apply for PA 08 164

Funding Number: PA 08 164
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Secondary Analysis of Existing Alcohol Epidemiology Data (R01) Apply for PA 08 167

Funding Number: PA 08 167
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Secondary Analysis of Existing Alcohol Epidemiology Data (R21) Apply for PA 08 168

Funding Number: PA 08 168
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Secondary Analysis of Existing Alcohol Epidemiology Data (R03) Apply for PA 08 169

Funding Number: PA 08 169
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Economics of Treatment and Prevention Services for Drug Alcohol Abuse (R21) Apply for PA 08 173

Funding Number: PA 08 173
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Integrative Systems Biology Approaches to Auditory Hair Cell Regeneration (R01) Apply for PA 08 177

Funding Number: PA 08 177
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrative Systems Biology Approaches to Auditory Hair Cell Regeneration (R21) Apply for PA 08 176

Funding Number: PA 08 176
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NIDCR Clinical Trial Planning Grant (R34) Apply for PAR 08 195

Funding Number: PAR 08 195
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Clinical Trial Planning Grant (R34) Apply for PAR 08 203

Funding Number: PAR 08 203
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Phase I/II Preliminary Clinical Trials in Communication Disorders (R01) Apply for PAR 08 204

Funding Number: PAR 08 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01) Apply for PAR 08 205

Funding Number: PAR 08 205
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Deep Sequencing and Haplotype Profiling of Mental Disorders (R01) Apply for PA 08 198

Funding Number: PA 08 198
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Addressing the Mental Health Needs of Returning Combat Veterans in the Community (R01) Apply for RFA MH 09 070

Funding Number: RFA MH 09 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Deep Sequencing and Haplotype Profiling of Mental Disorders (Collaborative R01) Apply for PAR 08 199

Funding Number: PAR 08 199
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 091", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.